Atlas FDA

Ventana PD-Ll (SP263) Assay

FDA premarket approval P160046/S006 · decided 2019-11-19

Approval details

PMA number
P160046
Supplement
S006
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Ventana PD-Ll (SP263) Assay
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Applicant
Ventana Medical Systems, Inc.
Date received
2019-08-22
Decision date
2019-11-19
Days to decision
89 days
Decision code
APPR
Product code
PLS
Advisory committee
Pathology
Expedited review
No
Location
Tucson, AZ
Statement
Approval for minor software and firmware updates for Ventana System Software on the BenchMark ULTRA instruments.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Roche Digital Pathology Dx (K242783)Ventana Medical Systems, Inc.2024-12-17
VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail (08507023001) (DEN240025)Ventana Medical Systems, Inc.2024-12-05
Roche Digital Pathology Dx (VENTANA DP 200) (K232879)Ventana Medical Systems, Inc.2024-06-14
CINtec Histology (K212176)Ventana Medical Systems, Inc.2021-12-10
VENTANA CD30 (Ber-H2) RxDx Assay (K172471)Ventana Medical Systems, Inc.2018-05-08
CINtec Histology (50 tests), CINtec Histology (250 tests) (DEN160019)Ventana Medical Systems, Inc.2017-03-04
Virtuoso System for IHC PR (1E2) using iScan HT (K142965)Ventana Medical Systems, Inc.2015-07-16
VIRTUOSO SYSTEM FOR IHC ER (SP1) WITH BENCHMARK ULTRA STAINER (K140465)Ventana Medical Systems, Inc.2014-03-20